Tumor-reactive T helper cells in the context of vaccination against glioma

被引：3

作者：

Zhao, Binghao ^{[1
,2
,5
]}

Kilian, Michael ^{[1
,2
,5
]}

Bunse, Theresa ^{[1
,2
,5
]}

Platten, Michael ^{[1
,2
,3
,4
,5
,6
,7
]}

Bunse, Lukas ^{[1
,2
,3
,5
]}

机构：

[1] German Canc Res Ctr, CCU Neuroimmunol & Brain Tumor Immunol, Heidelberg, Germany

[2] Heidelberg Univ, Med Fac Mannheim, Mannheim Ctr Translat Neurosci, Dept Neurol, Mannheim, Germany

[3] Univ Med Ctr Mannheim, DKFZ Hector Canc Inst, Mannheim, Germany

[4] DKFZ, Helmholtz Inst Translat Oncol Mainz Hitron Mainz H, Mainz, Germany

[5] German Canc Consortium DKTK, DKFZ, Core Ctr, Heidelberg, Germany

[6] DKFZ, Natl Ctr Tumor Dis NCT, Immune Monitoring Unit, Heidelberg, Germany

[7] Univ Hosp, Natl Ctr Tumor Dis NCT, Immune Monitoring Unit, Heidelberg, Germany

来源：

CANCER CELL | 2023年 / 41卷 / 11期

关键词：

D O I：

10.1016/j.ccell.2023.09.013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

With the advances in immunogenomics, the majority of tumor-specific antigens were found to be recognized by T helper cells (THCs). This observation led to the development of long epitope vaccines in various cancers. Mechanistically, we are still gaining a deeper understanding of the mode of action of THCs as precision anti-tumor agonists. Here, we discuss the specific cellular mechanisms of THC functions in glioma immunology and contextualize current advances in anti-glioma vaccination exploiting THCs.

引用

页码：1829 / 1834

页数：6

共 50 条

[21] Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues
Valmori, D
Fonteneau, JF
Valitutti, S
Gervois, N
Dunbar, R
Liénard, D
Rimoldi, D
Cerundolo, V
Jotereau, F
Cerottini, JC
Speiser, DE
Romero, P
INTERNATIONAL IMMUNOLOGY, 1999, 11 (12) : 1971 - 1979
[22] Peptide epitope identification for tumor-reactive CD4 T cells
Kobayashi, Hiroya
Celis, Esteban
CURRENT OPINION IN IMMUNOLOGY, 2008, 20 (02) : 221 - 227
[23] Tumor-associated galectin-3 modulates the function of tumor-reactive T cells
Peng, Weiyi
Wang, Helen Y.
Miyahara, Yoshihiro
Peng, Guangyong
Wang, Rong-Fu
CANCER RESEARCH, 2008, 68 (17) : 7228 - 7236
[24] Effects of tumor necrosis factor-α on the in vitro maturation of tumor-reactive effector T cells
Tanigawa, K
Craig, RA
Stoolman, LM
Chang, AE
JOURNAL OF IMMUNOTHERAPY, 2000, 23 (05) : 528 - 535
[25] REGULATION OF TUMOR-REACTIVE T-CELLS - IMPLICATIONS FOR TUMOR-REGRESSION VS PROGRESSION
CHAN, S
LI, WH
BISHOP, DK
FASEB JOURNAL, 1992, 6 (05): : A1690 - A1690
[26] Tumor-reactive CD4+CD8αβ+ CD103+ αβT cells: a prevalent tumor-reactive T-cell subset in metastatic colorectal cancers
Sarrabayrouse, Guillaume
Corvaisier, Murielle
Ouisse, Laure-Helene
Bossard, Celine
Le Mevel, Bernard
Potiron, Lucien
Meurette, Guillaume
Gervois, Nadine
Jotereau, Francine
INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (12) : 2923 - 2932
[27] Detection of HLA-independent tumor-reactive T cells in umbilical cord blood
Pannenbeckers, M.
Derigs, P.
Fruth, A.
Paschen, A.
Woelfel, T.
Woelfel, C.
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 137 - 137
[28] Mucin may not be the recognition antigen for autologous and heterologous pancreatic tumor-reactive T cells
Selvan, RS
10TH INTERNATIONAL CONGRESS ON IMMUNOLOGY, VOLS 1 AND 2, 1998, : 1123 - 1127
[29] CD137 as a Biomarker for Tumor-Reactive T Cells: Finding Gold in the Desert
Zhu, Yuwen
Chen, Lieping
CLINICAL CANCER RESEARCH, 2014, 20 (01) : 3 - 5
[30] The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells
Kuczma, Michal P.
Ding, Zhi-Chun
Li, Tao
Habtetsion, Tsadik
Chen, Tingting
Hao, Zhonglin
Bryan, Locke
Singh, Nagendra
Kochenderfer, James N.
Zhou, Gang
ONCOTARGET, 2017, 8 (67) : 111931 - 111942

← 1 2 3 4 5 →